HEXO

You Won’t Find Better Value Than Hexo Stock in the Canna-business

There are plenty of reasons to believe cannabis stocks will recover. Buying shares of Hexo stock now is one way to bet on that recovery.

Should Long-Term Investors Buy Hexo Stock Ahead of Earnings?

HEXO stock is down about 50% since late April. Are HEXO shares oversold heading into Thursday's earnings report?

Here’s How Millennials Can Save Hexo Stock … and Maybe its Cannabis Peers

Under traditional benchmarks of investing, Hexo stock is a major no-no. However, when you consider that millennials are the most interested in legal marijuana, HEXO suddenly enjoys a new angle.

Why I Continue to Stay Away From HEXO Stock

There are a lot of pot stocks out there. Most won't make it long term. Right now, HEXO stock belongs in the "won't make it" box.

Hexo Stock Is Teetering on a Must-Hold Level

Throughout the entire legal marijuana industry, a sea of red ink plagues many competitors. However, HEXO has an extremely rich valuation. If the Hexo stock price doesn’t start showing upside momentum, it could be in for some real pain.

Hexo Stock Is Down — But Not Out

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

Don’t Buy Hexo Stock as It Continues to Drop

Hexo stock keeps going down, but that doesn't mean it's cheap yet. Here's why, even at $4, you should still be cautious with Hexo stock.

Here’s How to Buy Hexo Stock Now

The cannabis industry remains rife with speculation, but Hexo stock has advantages off and on the price chart making it worthy of a place in your portfolio

Hexo Stock Requires Patience, Flair for Risk

What makes Hexo stock risky over the near-term, particularly for those perceiving value here, is that there's actually a lot to like with this name. Hexo has enviable partnerships and a compelling business model that it, for the most part, executes well on. However, the broader cannabis investment space is largely out of favor with investors at the moment and that is a significant headwind for Hexo stock.

Hexo’s “Smoke-Free” Strategy Is Solid, but Shares Remain Overvalued

The Hexo stock price remains inflated. Investors are betting on the company's future potential. Long-term, shares could see big gains. But short-term volatility is a risk. Keep HEXO on your radar. But tread carefully before entering a position.

Hexo Stock Smokes its Competition

In an emerging industry like cannabis, when one stock drops, they all drop. But a look at Hexo shows not all cannabis companies are the same.

Especially Under Current Conditions, Stay Far Away from Hexo Stock

Hexo stock is too dangerous to deal with right now, even though the company is doing everything it's supposed to be doing at a manageable pace.

Hexo Stock Drops as the Company Continues to Lose Money

HEXO stock has dropped by 50% in just four months. Investors are now coming to terms with the fact that the company is losing money.

Hexo Stock Is a Good Trade for the Brave but Definitely Not an Investment

Bearish on Hexo stock with concerns of cannabis oversupply, cash burn, equity dilution and strong competition.

Hexo Stock Continues to Feel the Effects of Cannabis Industry Issues

HEXO is feeling the impact of a poor Q3 showing, the stepping down of a co-founder and a sluggish recreational cannabis market.

Will Hexo Stock Be Around for the Long Haul?

Hexo is one of the fastest growing marijuana stocks. But now may not be the right time to invest in Hexo stock.

Why Investors Should Trade Cautiously With Hexo Stock

Markets are avoiding cannabis stocks, taking Hexo stock lower. What does it take to win back investors when it reports next month?

10 Marijuana Stocks That Could See 100% Gains, If Not More

Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.

The 10 Best Marijuana Stocks to Buy Now

Wall Street’s impatience to see progress on the bottom line have hurt marijuana stocks. However, positive catalysts, such as a support political environment and individual companies’ push toward mainstreaming cannabis bolster the case for the embattled weed market.